181 related articles for article (PubMed ID: 1666442)
1. Vaccination against herpesvirus, fiction or reality?
Morein B; Merza M
Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
3. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
4. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
5. Marek's disease in turkeys: lack of protection by vaccination.
Elmubarak AK; Sharma JM; Witter RL; Sanger VL
Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
8. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
Hamers C; Juillard V; Fischer L
J Comp Pathol; 2007 Jul; 137 Suppl 1():S35-41. PubMed ID: 17553517
[TBL] [Abstract][Full Text] [Related]
11. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
[TBL] [Abstract][Full Text] [Related]
13. Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease.
Purchase HG; Okazaki W; Burmester BR
Avian Dis; 1972 Apr; 16(1):57-71. PubMed ID: 4337318
[No Abstract] [Full Text] [Related]
14. Infectious bovine rhinotracheitis: study on the experimentally induced disease and its prevention using an inactivated, adjuvanted vaccine.
Soulebot JP; Guillemin F; Brun A; Dubourget P; Espinasse J; Terre J
Dev Biol Stand; 1982; 52():463-83. PubMed ID: 6299856
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).
Biront P; Vandeputte J; Pensaert MB; Leunen J
Am J Vet Res; 1982 May; 43(5):760-3. PubMed ID: 6283963
[TBL] [Abstract][Full Text] [Related]
16. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
Niedobitek G; Agathanggelou A; Finerty S; Tierney R; Watkins P; Jones EL; Morgan A; Young LS; Rooney N
Am J Pathol; 1994 Oct; 145(4):969-78. PubMed ID: 7943186
[TBL] [Abstract][Full Text] [Related]
17. The use of marker vaccines in eradication of herpesviruses.
van Oirschot JT; Kaashoek MJ; Rijsewijk FA; Stegeman JA
J Biotechnol; 1996 Jan; 44(1-3):75-81. PubMed ID: 8717389
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against diseases associated with herpesvirus infections in animals: a review.
Plowright W
IARC Sci Publ (1971); 1978; (24 Pt 2):965-80. PubMed ID: 221416
[TBL] [Abstract][Full Text] [Related]
20. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
